Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
CD8(+) T cells in multiple sclerosis.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Progressive multiple sclerosis: pathology and pathogenesis.
Pathology of multiple sclerosis: where do we stand?
Role of early viral infections in development of multiple sclerosis.
Experience with Fingolimod in Clinical Practice.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
258
259
260
261
262
263
264
265
266
…
next ›
last »